Details

Last Funding Type

Series B

Last Funding Money Raised

$4M

Industries

Biopharma,Biotechnology,Medical

Founded date

Jan 1, 1999

Number Of Employee

1 - 10

Operating Status

Active

Interomex Biopharmaceuticals Inc. is dedicated to the identification of novel biological targets in key cellular processes with the aim of discovering lead compounds for the treatment of disease.

The company’s proprietary Repressed Trans-activator (RTATM) technology can be used to detect protein-protein interactions between a host and an infectious agent, as well as within cells in normal and diseased states. A particular advantage of RTATM is its ability to detect the interactions of transcription transactivator proteins, which are key control points in viral infections and cell activation.